Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
Saved in:
Main Authors: | Assad Shiti, Idit Goldfracht, Naim Shaheen, Stephanie Protze, Lior Gepstein |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/419b4694c7dd4aeca6ebb99f29e4bade |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes
by: Idit Goldfracht, et al.
Published: (2020) -
Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
by: Torsten Christ, et al.
Published: (2021) -
Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue
by: Zachary Laksman, et al.
Published: (2017) -
Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors
by: Erez Marcusohn, et al.
Published: (2021) -
Atrial Myopathy Underlying Atrial Fibrillation
by: Harold Rivner, et al.
Published: (2020)